Orsi Giricz

1.6k total citations
23 papers, 567 citations indexed

About

Orsi Giricz is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Orsi Giricz has authored 23 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Hematology. Recurrent topics in Orsi Giricz's work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Orsi Giricz is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Orsi Giricz collaborates with scholars based in United States, United Kingdom and Ukraine. Orsi Giricz's co-authors include Paraic A. Kenny, Amit Verma, Gregg B. Fields, Verónica Calvo, Yiting Yu, Tushar D. Bhagat, Janelle L. Lauer‐Fields, Carolina Schinke, Ulrich Steidl and Laura Barreyro and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Orsi Giricz

21 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orsi Giricz United States 11 347 172 125 106 104 23 567
Azin Sayad Canada 10 425 1.2× 214 1.2× 117 0.9× 142 1.3× 57 0.5× 21 651
Samar Alsafadi France 12 525 1.5× 151 0.9× 126 1.0× 94 0.9× 66 0.6× 24 672
Antreas Hindoyan United States 11 409 1.2× 365 2.1× 128 1.0× 114 1.1× 125 1.2× 24 767
Pedro Marques Ramos Switzerland 9 251 0.7× 161 0.9× 90 0.7× 65 0.6× 184 1.8× 18 557
Arvind Singh Mer Canada 11 311 0.9× 182 1.1× 196 1.6× 43 0.4× 55 0.5× 24 577
Valentina Serafin Italy 14 545 1.6× 162 0.9× 294 2.4× 110 1.0× 96 0.9× 28 783
Matias Casás‐Selves United States 8 350 1.0× 175 1.0× 126 1.0× 75 0.7× 42 0.4× 9 549
Eliezer Shochat Switzerland 12 302 0.9× 234 1.4× 59 0.5× 73 0.7× 39 0.4× 17 588
Swapnil Potdar Finland 12 251 0.7× 176 1.0× 100 0.8× 41 0.4× 86 0.8× 40 538
André Schultz United States 6 358 1.0× 211 1.2× 205 1.6× 65 0.6× 29 0.3× 12 601

Countries citing papers authored by Orsi Giricz

Since Specialization
Citations

This map shows the geographic impact of Orsi Giricz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsi Giricz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsi Giricz more than expected).

Fields of papers citing papers by Orsi Giricz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orsi Giricz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsi Giricz. The network helps show where Orsi Giricz may publish in the future.

Co-authorship network of co-authors of Orsi Giricz

This figure shows the co-authorship network connecting the top 25 collaborators of Orsi Giricz. A scholar is included among the top collaborators of Orsi Giricz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orsi Giricz. Orsi Giricz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giricz, Orsi, Rachel Zeig‐Owens, Kith Pradhan, et al.. (2023). 2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.. Experimental Hematology. 124. S41–S41.
2.
Zeig‐Owens, Rachel, David G. Goldfarb, Benjamin J. Luft, et al.. (2022). Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster. Blood Cancer Journal. 12(8). 120–120. 2 indexed citations
3.
Cotto-Rios, Xiomaris M., Bogos Agianian, Nadege Gitego, et al.. (2020). Inhibitors of BRAF dimers using an allosteric site. Nature Communications. 11(1). 4370–4370. 52 indexed citations
4.
Ramachandra, Nandini, Tushar D. Bhagat, Shanisha Gordon, et al.. (2019). ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations. Blood. 134(Supplement_1). 2989–2989. 2 indexed citations
5.
Schinke, Carolina, Orsi Giricz, Weijuan Li, et al.. (2015). IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 125(20). 3144–3152. 145 indexed citations
6.
Han, Ju, Hang Chang, Orsi Giricz, et al.. (2015). Text S1 - Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture. Figshare. 44 indexed citations
7.
Mohtat, Davoud, Yiting Yu, Yi-An Ko, et al.. (2014). Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival. Clinical Cancer Research. 20(16). 4349–4360. 55 indexed citations
8.
Hussain, Zulfiqar, et al.. (2014). Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle. 13(21). 3320–3327. 28 indexed citations
9.
Shastri, Aditi, Carolina Schinke, Tushar D. Bhagat, et al.. (2014). Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine. Blood. 124(21). 3602–3602. 6 indexed citations
10.
Bhagat, Tushar D., Matthias Bartenstein, Yiting Yu, et al.. (2014). Myelodysplastic Syndrome Marrow Stroma Shows Widespread Aberrant Hypermethylation That Is Abrogated By Treatment with Dnmt Inhibitors. Blood. 124(21). 4379–4379. 2 indexed citations
11.
Bowler, Timothy G., Matthias Bartenstein, Kerry Morrone, et al.. (2014). Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects. Blood. 124(21). 4591–4591. 2 indexed citations
12.
Koba, Wade, et al.. (2013). Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology. 23(12). 1477–1490. 29 indexed citations
13.
Calvo, Verónica, Orsi Giricz, & Paraic A. Kenny. (2013). Abstract A54: TACE-regulated TGF-alpha shedding drives GRB7-dependent invasion in triple-negative breast cancer cell lines. Cancer Research. 73(3_Supplement). A54–A54. 1 indexed citations
14.
15.
Giricz, Orsi, et al.. (2013). TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion. International Journal of Cancer. 133(11). n/a–n/a. 30 indexed citations
16.
Bhagat, Tushar D., Yanique Rattigan, Brijesh Patel, et al.. (2013). Abstract 1504: Pancreatic cancer associated fibroblasts are characterized by widespread epigenetic reprogramming that leads to aberrant expression of druggable target CXCR4.. Cancer Research. 73(8_Supplement). 1504–1504. 1 indexed citations
17.
Giricz, Orsi, Paul A. Reynolds, Christina Liu, et al.. (2011). Hsa‐miR‐375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. The Journal of Pathology. 226(1). 108–119. 61 indexed citations
18.
Giricz, Orsi, Verónica Calvo, Stephanie C. Pero, et al.. (2011). GRB7 is required for triple-negative breast cancer cell invasion and survival. Breast Cancer Research and Treatment. 133(2). 607–615. 49 indexed citations
19.
Giricz, Orsi, Janelle Lauer, & Gregg B. Fields. (2010). Comparison of metalloproteinase protein and activity profiling. Analytical Biochemistry. 409(1). 37–45. 9 indexed citations
20.
Giricz, Orsi, Janelle L. Lauer‐Fields, & Gregg B. Fields. (2008). The normalization of gene expression data in melanoma: Investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR. Analytical Biochemistry. 380(1). 137–139. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azin Sayad Breakdown of academic impact, for papers by Samar Alsafadi Breakdown of academic impact, for papers by Antreas Hindoyan Breakdown of academic impact, for papers by Pedro Marques Ramos Breakdown of academic impact, for papers by Arvind Singh Mer Breakdown of academic impact, for papers by Valentina Serafin Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Eliezer Shochat Breakdown of academic impact, for papers by Swapnil Potdar Breakdown of academic impact, for papers by André Schultz
Rankless by CCL
2026